Pregnant women's choices for preventing respiratory syncytial virus (RSV)

被引:0
|
作者
Wang, Bing [1 ,2 ,3 ]
Lassi, Zohra [4 ,5 ]
Andraweera, Prabha [1 ,2 ,3 ]
Chen, Gang [6 ]
Ong, Jason J. [7 ,8 ]
Mcmillian, Mark [1 ,2 ,3 ]
Marshall, Helen [1 ,2 ,3 ]
机构
[1] Womens & Childrens Hlth Network, Vaccinol & Immunol Res Trials Unit, 72 King William Rd, Adelaide, SA 5006, Australia
[2] Univ Adelaide, Robinson Res Inst, Adelaide, SA, Australia
[3] Univ Adelaide, Adelaide Med Sch, Adelaide, SA, Australia
[4] Univ Adelaide, Robinson Res Inst, Adelaide, Australia
[5] Univ Adelaide, Fac Hlth & Med Sci, Sch Publ Hlth, Adelaide, Australia
[6] Univ Melbourne, Sch Populat & Global Hlth, Melbourne, Vic, Australia
[7] Monash Univ, Sch Translat Med, Melbourne, Vic, Australia
[8] London Sch Hyg & Trop Med, Fac Infect & Trop Dis, London, England
关键词
RSV; Maternal vaccine; Vaccine attitudes; Qualitative; Vaccine promotion; VACCINATION; CHALLENGES; CHILDREN;
D O I
10.1016/j.vaccine.2025.126790
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Introduction: Respiratory syncytial virus (RSV) is the leading cause of bronchiolitis and pneumonia in infants and can lead to severe respiratory distress, especially in very young infants. No specific treatments exist for RSV. However, new preventative strategies have become available including RSV vaccine for pregnant women and monoclonal antibody for infants. This study aimed to identify and understand barriers and facilitators to the uptake of a new RSV vaccine in pregnant women and determine their underlying choices for a maternal RSV immunisation program. Additionally, the study investigated choice for maternal vaccination or administration of a long-lasting monoclonal antibody to infants. Methods: Eligible participants were pregnant women residing in Australia and aged 18 years or older. Focus group discussions and individual online interviews were conducted and data were analysed using a thematic analysis approach. Results: A total of 34 pregnant women participated in online focus group discussions or interviews, with an average age of 34 years. The identified themes were categorised into four overarching domains: 1) motivators for vaccinating during pregnancy to safeguard their babies and prevent severe diseases, 2) barriers to vaccination including vaccine safety concerns, uncertainties regarding vaccine effectiveness, and vaccine hesitancy arising from COVID-19 vaccination experiences, 3) preferred vaccination promotion strategies, including constant reminders/prompts, personalised messages, campaign focusing on serious outcomes and using diverse/lay languages, recommendations from local obstetricians and health authorities, 4) clear vaccine recommendation policies and a preference for maternal immunisation over infant immunisation. Conclusions: The maternal RSV vaccination was generally welcomed and preferred by pregnant women in our study comparing to other strategies. Preferences for RSV program promotion included diversity in languages, "nudge" reminders, and recommendations from healthcare providers.
引用
收藏
页数:7
相关论文
共 50 条
  • [1] Prospective Attitudes Towards Respiratory Syncytial Virus (RSV) Vaccine in Pregnant Women in Greece
    Damatopoulou, Anna
    Matalliotakis, Michail
    Diamanta, Ypatia
    Pikrides, Ioannis
    Ierapetritis, Emmanouil
    Kakouri, Persefoni
    Fraidakis, Matthaios
    Ladomenou, Fani
    BEHAVIORAL MEDICINE, 2025, 51 (01) : 1 - 6
  • [2] Respiratory Syncytial Virus (RSV)-Specific Antibodies in Pregnant Women and Subsequent Risk of RSV Hospitalization in Young Infants
    Koivisto, Karoliina
    Nieminen, Tea
    Mejias, Asuncion
    Capella Gonzalez, Cristina
    Ye, Fang
    Mertz, Sara
    Peeples, Mark
    Ramilo, Octavio
    Saxen, Harri
    JOURNAL OF INFECTIOUS DISEASES, 2022, 225 (07): : 1189 - 1196
  • [3] Palivizumab for preventing severe respiratory syncytial virus (RSV) infection in children
    Garegnani, Luis
    Styrmisdottir, Lea
    Roson Rodriguez, Pablo
    Escobar Liquitay, Camila Micaela
    Esteban, Ignacio
    Franco, Juan V. A.
    COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2021, (11):
  • [4] The adult respiratory syncytial virus The Respiratory Syncytial Virus (RSV) in Adults
    Frenzen, F.
    Mueller, G.
    Frenzen, K.
    PNEUMOLOGIE, 2020, 74 (06): : 374 - 386
  • [6] Respiratory Syncytial Virus (RSV) Update
    Krilov, Leonard R.
    Roberts Jr, Norbert
    VIRUSES-BASEL, 2022, 14 (10):
  • [7] Pathobiology of Respiratory Syncytial Virus (RSV)
    Tripp, Ralph A.
    McNamara, Paul S.
    VACCINES, 2020, 8 (03)
  • [8] RESPIRATORY SYNCYTIAL VIRUS (RSV) OR ROUS-SARCOMA VIRUS (RSV)
    LINDHARDT, BO
    CHEST, 1995, 108 (01) : 292 - 292
  • [9] Effects of Montelukast in Preventing Respiratory Syncytial Virus (RSV)-Induced Airway Hyperresponsiveness and Inflammation
    Han, J.
    Jia, Y.
    Shiraishi, Y.
    Takeda, K.
    Okamoto, M.
    Dakhama, A.
    Gelfand, E. W.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2009, 179
  • [10] Uptake of the Respiratory Syncytial Virus (RSV) Vaccine and Nirsevimab Among Pregnant Patients and Their Neonates
    Blauvelt, C. A.
    Natarajan, A.
    Gaw, S. L.
    AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 2024, 231 (06)